{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:45:45Z","timestamp":1793133945906,"version":"4.5.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:sec id=\"ab-soi250086-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Studying the molecular profiles of mixed-type and branch-duct (BD) intraductal papillary mucinous neoplasms (IPMNs) is important to understand the underlying biological basis for higher malignant potential of mixed-type IPMNs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi250086-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare mutation patterns in mixed-type vs BD-IPMNs through cyst fluid next-generation sequencing (NGS) analysis using PancreaSeq NGS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi250086-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>\n                      For this cohort study, pancreatic cyst fluid specimens from 31 medical centers were sent to a centralized NGS lab for analysis between January 2018 and February 2020. Patients with IPMNs (based on\n                      <jats:italic toggle=\"yes\">KRAS<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">GNAS<\/jats:italic>\n                      mutant status) and with available main pancreatic duct (MPD) size data were included. Patients with main-duct IPMNs and with MPD 10 mm or greater were excluded. Mixed-type IPMNs were defined as IPMNs with an MPD of 5 to 9 mm, and BD-IPMNs were defined as IPMNs with an MPD less than 5 mm. High-risk mutations (HRMs) were categorized as alterations in\n                      <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">SMAD4<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">CTNNB1<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">mTOR<\/jats:italic>\n                      genes. Advanced neoplasia was defined as IPMNs with invasive carcinoma or high-grade dysplasia. Data were analyzed from June 1 to 5, 2025.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi250086-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Primary outcomes included rates of HRMs and the co-occurrence of 2 or more HRMs in mixed-type IPMNs and BD-IPMNs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi250086-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 674 patients with IPMNs, 202 had mixed-type IPMN, and 472 had BD-IPMN. There were 379 female patients (56.2%) and 295 male patients (43.8%); the mean (SD) age was 70.3 (9.6) years. HRMs were observed in 106 patients (16%), with\n                      <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                      ,\n                      <jats:italic toggle=\"yes\">SMAD4<\/jats:italic>\n                      , and\n                      <jats:italic toggle=\"yes\">MTOR<\/jats:italic>\n                      mutations more common in mixed-type IPMNs. Of the 674 patients, 167 patients underwent surgical resection, and these 167 patients had final surgical pathology available. Overall, mixed-type IPMNs had significantly higher rates of HRMs (62 [31%] vs 44 [9.3%];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) and co-occurrence of 2 or more HRMs (25 [12.4%] vs 14 [3%];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001) compared with BD-IPMNs. On multivariate logistic regression, mixed-type IPMNs were independently associated with HRMs (odds ratio, 3.42; 95% CI, 1.72-6.82). Preoperative NGS detection of HRMs showed 90% sensitivity, 100% specificity, a positive predictive value (PPV) of 100%, and a negative predictive value (NPV) of 86% for predicting advanced neoplasia in mixed-type IPMNs. The presence of any worrisome feature or high-risk stigmata showed a sensitivity of 100%, very low specificity of 13.3%, PPV of 67%, and NPV of 100%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-soi250086-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This study found that mixed-type IPMNs are more likely to harbor HRMs associated with advanced neoplasia. Cyst fluid NGS is highly sensitive and specific for predicting advanced neoplasia in patients with mixed-type IPMNs and should therefore be considered to help upgrade or downgrade risk based on the presence or absence of other worrisome features.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2025.5692","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:00:31Z","timestamp":1766505631000},"page":"171","source":"Crossref","is-referenced-by-count":5,"title":["Molecular Analysis of Mixed-Type and Branch-Duct Intraductal Papillary Mucinous Neoplasms"],"prefix":"10.1001","volume":"161","author":[{"given":"Amudhan","family":"Kannan","sequence":"first","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert Z.","family":"Murimwa","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Mansour","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary A.","family":"Whitham","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Jones","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha K.","family":"Sheth","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Abbas","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhi","family":"Deverakonda","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Sawas","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Ellis","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrikus S.","family":"Vanderveldt","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Coleman","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Foley","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tavakkoli","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Goldschmeidt","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Rajamohan","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Khatri","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall E.","family":"Brand","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina N.","family":"Nikiforova","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Paniccia","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer H.","family":"Zureikat","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K.W.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Fleming","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert J.","family":"Zeh","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisa M.","family":"Kubiliun","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aatur D.","family":"Singhi","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio M.","family":"Polanco","sequence":"additional","affiliation":[{"name":"Pancreatic Cancer Prevention Program, University of Texas Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"4","key":"soi250086r1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.gastro.2012.01.005","article-title":"Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.","volume":"142","author":"Canto","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"soi250086r2","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1053\/j.gastro.2015.01.014","article-title":"American Gastroenterological Association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts.","volume":"148","author":"Scheiman","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"soi250086r3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000489641","article-title":"Pancreatic cystic neoplasms: different types, different management, new guidelines.","volume":"34","author":"Scholten","year":"2018","journal-title":"Visc Med"},{"issue":"3","key":"soi250086r4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.hpb.2015.10.010","article-title":"Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.","volume":"18","author":"Rezaee","year":"2016","journal-title":"HPB (Oxford)"},{"issue":"3","key":"soi250086r5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pan.2012.04.004","article-title":"International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.","volume":"12","author":"Tanaka","year":"2012","journal-title":"Pancreatology"},{"issue":"5","key":"soi250086r6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"issue":"2","key":"soi250086r7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","article-title":"International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas.","volume":"24","author":"Ohtsuka","year":"2024","journal-title":"Pancreatology"},{"issue":"9","key":"soi250086r8","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1007\/s10620-015-3679-8","article-title":"Rapid growth rates of suspected pancreatic cyst branch duct intraductal papillary mucinous neoplasms predict malignancy.","volume":"60","author":"Kwong","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"5","key":"soi250086r9","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.surg.2015.04.029","article-title":"Acute pancreatitis in intraductal papillary mucinous neoplasms: a common predictor of malignant intestinal subtype.","volume":"158","author":"Morales-Oyarvide","year":"2015","journal-title":"Surgery"},{"issue":"6","key":"soi250086r10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/XCS.0000000000000176","article-title":"Number of worrisome features and risk of malignancy in intraductal papillary mucinous neoplasm.","volume":"234","author":"Zelga","year":"2022","journal-title":"J Am Coll Surg"},{"issue":"3","key":"soi250086r11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.pan.2023.02.008","article-title":"Surveillance after resection of non-invasive intraductal papillary mucinous neoplasms (IPMN): a systematic review.","volume":"23","author":"Correa-Gallego","year":"2023","journal-title":"Pancreatology"},{"issue":"4","key":"soi250086r12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/SLA.0b013e318155a9e5","article-title":"Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology.","volume":"246","author":"Schmidt","year":"2007","journal-title":"Ann Surg"},{"issue":"6","key":"soi250086r13","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/01.sla.0000128306.90650.aa","article-title":"Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.","volume":"239","author":"Sohn","year":"2004","journal-title":"Ann Surg"},{"issue":"3","key":"soi250086r14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1053\/j.gastro.2010.07.025","article-title":"Intraductal papillary mucinous neoplasms of the pancreas.","volume":"139","author":"Fern\u00e1ndez-del Castillo","year":"2010","journal-title":"Gastroenterology"},{"issue":"5","key":"soi250086r15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/SLA.0000000000000980","article-title":"Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.","volume":"260","author":"Fritz","year":"2014","journal-title":"Ann Surg"},{"issue":"6","key":"soi250086r16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1001\/jamasurg.2021.0528","article-title":"STROBE reporting guidelines for observational studies.","volume":"156","author":"Ghaferi","year":"2021","journal-title":"JAMA Surg"},{"issue":"12","key":"soi250086r17","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1136\/gutjnl-2016-313586","article-title":"Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.","volume":"67","author":"Singhi","year":"2018","journal-title":"Gut"},{"issue":"1","key":"soi250086r18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.gastro.2022.09.028","article-title":"Prospective, multi-institutional, real-time next-generation sequencing of pancreatic cyst fluid reveals diverse genomic alterations that improve the clinical management of pancreatic cysts.","volume":"164","author":"Paniccia","year":"2023","journal-title":"Gastroenterology"},{"issue":"4","key":"soi250086r19","doi-asserted-by":"publisher","first-page":"e789","DOI":"10.1097\/SLA.0000000000005904","article-title":"A combined DNA\/RNA-based next-generation sequencing platform to improve the classification of pancreatic cysts and early detection of pancreatic cancer arising from pancreatic cysts.","volume":"278","author":"Nikiforova","year":"2023","journal-title":"Ann Surg"},{"issue":"16","key":"soi250086r20","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1158\/1078-0432.CCR-14-0513","article-title":"Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.","volume":"20","author":"Singhi","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"5","key":"soi250086r21","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.ejso.2021.11.137","article-title":"Malignant potential and specific characteristics of pure main duct type intraductal papillary mucinous neoplasm.","volume":"48","author":"Fujita","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"soi250086r22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.surg.2015.06.003","article-title":"Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.","volume":"158","author":"Ceppa","year":"2015","journal-title":"Surgery"},{"issue":"3","key":"soi250086r23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.surg.2014.04.023","article-title":"Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.","volume":"156","author":"Sahora","year":"2014","journal-title":"Surgery"},{"issue":"7","key":"soi250086r24","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1111\/j.1440-1746.2009.05826.x","article-title":"Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas.","volume":"24","author":"Bournet","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"soi250086r25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cgh.2009.10.001","article-title":"Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics.","volume":"8","author":"Crippa","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"soi250086r26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00535-011-0482-y","article-title":"Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progression.","volume":"47","author":"Mohri","year":"2012","journal-title":"J Gastroenterol"},{"issue":"1","key":"soi250086r27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/SLA.0000000000003108","article-title":"New model for predicting malignancy in patients with intraductal papillary mucinous neoplasm.","volume":"272","author":"Shimizu","year":"2020","journal-title":"Ann Surg"},{"issue":"6","key":"soi250086r28","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/SLA.0000000000001985","article-title":"Proposed nomogram predicting the individual risk of malignancy in the patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas.","volume":"266","author":"Jang","year":"2017","journal-title":"Ann Surg"},{"issue":"5","key":"soi250086r29","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/SLA.0000000000001462","article-title":"Main-duct intraductal papillary mucinous neoplasm: high cancer risk in duct diameter of 5 to 9?mm.","volume":"262","author":"Hackert","year":"2015","journal-title":"Ann Surg"},{"issue":"1","key":"soi250086r30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.surg.2011.07.009","article-title":"An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas.","volume":"151","author":"Ohtsuka","year":"2012","journal-title":"Surgery"},{"issue":"3","key":"soi250086r31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/MPA.0000000000000269","article-title":"Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers.","volume":"44","author":"Shimizu","year":"2015","journal-title":"Pancreas"},{"issue":"11","key":"soi250086r32","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1245\/s10434-014-3739-x","article-title":"Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study.","volume":"21","author":"Lennon","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"soi250086r33","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.gie.2017.12.019","article-title":"Pancreatic cancer screening in high-risk individuals with germline genetic mutations.","volume":"87","author":"DaVee","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"soi250086r34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jamcollsurg.2019.09.019","article-title":"Abdominal imaging of pancreatic cysts and cyst-associated pancreatic cancer in BRCA1\/2 mutation carriers: a retrospective cross-sectional study.","volume":"230","author":"Cao","year":"2020","journal-title":"J Am Coll Surg"},{"issue":"3","key":"soi250086r35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3390\/ijms20030561","article-title":"Genomic features and clinical management of patients with hereditary pancreatic cancer syndromes and familial pancreatic cancer.","volume":"20","author":"Ohmoto","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2843248\/jamasurgery_kannan_2025_oi_250086_1770066736.77747.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T16:00:22Z","timestamp":1770825622000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2843248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2025.5692","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}